State Boards Are Paying More Attention to Medical Spas
By Patrick O’Brien, JD, General Counsel, American Med Spa Association
If it seems like state regulators are paying more attention to medical spas, IV clinics and wellness practices, that is because they are.
Over the last several years state medical, nursing and pharmacy boards have been issuing guidance directed specifically at the services commonly offered in medical spas and wellness practices (see here for example). Over the last several months more states have joined this trend including New Jersey, New Mexico, Maine, West Virginia, Virginia and Arkansas. The subjects vary from state to state, but often include IV hydration, aesthetics, GLP-1 medications, peptides and compounding, and the overall message is remarkably consistent: These businesses are medical practices, and regulators expect them to operate like medical practices. Before we look at some of the details, it is important to understand that for the most part these guidance statements are clarifying and explaining what the current laws and rules are rather than making new policy or changing the rules.
A Familiar Message on IV Therapy
In general, these states’ guidance on IV hydration make clear that it is a medical treatment. A patient needs an appropriate evaluation and patient-specific order from a practitioner with prescribing authority. Standing orders generally cannot replace the medical judgment involved in determining whether a particular treatment is appropriate for a particular patient. The person administering the treatment must have the proper license, training and authority, and delegated care requires appropriate supervision.
Those concepts aren’t particularly new. What is changing is the number of regulators taking the time to specifically apply them to medical spas, IV clinics and other non-traditional medical settings.
New Jersey’s recent guidance is probably the clearest example. Its multi-board circular addresses medical spas and IV businesses directly and covers ownership, prescribing, delegation, supervision, telemedicine, cosmetology and compounding. Among other things, it makes clear that patients cannot simply select prescription ingredients from an IV “menu” and that a generally applicable standing order cannot substitute for an individualized evaluation.
West Virginia’s nursing board has similarly published a resource addressing IV hydration, aesthetic and medical spa services. It likewise emphasizes individualized assessment and treatment planning and warns against menu-based IV selection.
Arkansas’s nursing board has proposed position statements addressing both IV hydration and medical aesthetics. The IV proposal would clarify that practitioners must use patient-specific orders, appropriate examinations, competency documentation and emergency procedures, while rejecting generic standing orders as a substitute for individualized medical decision-making. Its aesthetics proposal similarly focuses on training, treatment plans, prescriber involvement and emergency preparedness. Those statements should not yet be treated as final board policy.
Virginia’s guidance follows many of the same themes, addressing the patient evaluation and treatment process, the appropriate roles of nurses and other personnel, and an issue that is becoming increasingly important: what happens when substances are added to an IV bag.
Compounding Moves to Center Stage
Many states have relatively clear rules on who could prescribe and administer IV treatments, but provided relatively little direct guidance about who could mix IV solutions in the office. This is an area where these guidance documents provide substantial clarification. The New Jersey guidance expressly addresses medication storage and compounding and points practices toward USP standards and pharmacy requirements. West Virginia’s guidance states that adding a drug, vitamin, mineral or amino acid to an IV solution constitutes compounding. Virginia has likewise clarified that compounding, including adding substances to saline bags, implicates pharmacy practice requirements.
At the same time, regulators are also issuing guidance on other areas of compounding to include compounded GLP-1 medications and peptides. Last year many states adopted strengthened rules regarding compounding (see here) and recently the HHS has issued a new policy related to peptides.
New Mexico recently approved guidance addressing safe prescribing of GLP-1 medications, including telehealth evaluations, compounded products, delegation, patient monitoring and advertising. Alabama’s pharmacy board has issued guidance addressing 503A compounding of GLP-1 medications, while its medical board has discussed the federal enforcement policy involving several peptide bulk drug substances.
The common thread is important. What previously may have been viewed as separate regulatory topics, IV hydration, weight loss, peptides and aesthetics, are increasingly being examined as parts of the same medical spa and wellness ecosystem.
The Larger Trend
None of this means that state boards suddenly discovered medical spas in 2026. Medical aesthetic treatments have always been subject to professional licensing, scope-of-practice, prescribing and supervision laws.
What has changed is the industry’s size, visibility and range of services.
Today’s medical spa may provide neurotoxins and fillers alongside IV hydration, medical weight loss, compounded medications, and lifestyle and wellness therapies. Services that previously occupied separate regulatory silos are increasingly being offered under one roof and regulators have noticed.
For compliant practices, that should not necessarily be viewed as bad news. Clearer guidance can reduce the uncertainty that has historically made medical-spa compliance difficult. But practices should not assume that something is acceptable simply because it has become common in the marketplace. A certification is not the same thing as professional licensure. A medical director agreement is not a substitute for a patient-practitioner relationship. A standing order is not necessarily a prescription. And purchasing or mixing a product does not avoid the pharmacy and compounding rules that may apply to it.
With the issuing of these new guidance documents, it is an excellent time for medical spa and wellness practices to review their current policies and procedures to ensure that they are still compliant with their state’s rules. Even if your state has not yet issued these types of guidance, it is a prudent practice to perform a compliance audit from time to time.
AmSpa Members: Take advantage of your annual consult with national healthcare law firm ByrdAdatto to discuss the finer details of med spa compliance in your state.
